Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProQuad vs M-M-R II and VARIVAX in healthy children
NCT00975507Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Mar 1998
- Primary completion
- Jan 1999
- Modality
- Live Attenuated Vaccines
01
Overview
A Phase 3 trial of varicella virus vaccine live in measles, mumps, rubella, varicella (VZV), sponsored by Merck & Co.. Started Mar 1998; status: completed.
02
Drugs
varicella virus vaccine live
03
Conditions
measlesmumpsrubellavaricella (VZV)
Beyond the preview
Go deeper on NCT00975507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00975507.